Literature DB >> 24525607

Fidaxomicin for Clostridium difficile Colitis in a peritoneal dialysis patient with underlying mitochondriopathy.

M Windpessl1, M Wallner.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24525607      PMCID： PMC3923709          DOI： 10.3747/pdi.2013.00040

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN： 0896-8608            Impact factor:   1.756


× No keyword cloud information.
  5 in total

1.  M.3243A>G: many faces of one single point mutation.

Authors:  Martin Windpessl; Manfred Wallner
Journal:  Wien Klin Wochenschr       Date:  2010-10       Impact factor: 1.704

2.  Fidaxomicin versus vancomycin for Clostridium difficile infection.

Authors:  Thomas J Louie; Mark A Miller; Kathleen M Mullane; Karl Weiss; Arnold Lentnek; Yoav Golan; Sherwood Gorbach; Pamela Sears; Youe-Kong Shue
Journal:  N Engl J Med       Date:  2011-02-03       Impact factor: 91.245

3.  Development of Clostridium difficile colitis in peritoneal dialysis patients treated for peritonitis.

Authors:  D F Wolfgram; D Foster; B C Astor; M R Chan
Journal:  Perit Dial Int       Date:  2012 Nov-Dec       Impact factor: 1.756

4.  Rapid-onset, linezolid-induced lactic acidosis in MELAS.

Authors:  Thomas E Cope; Robert McFarland; Andrew Schaefer
Journal:  Mitochondrion       Date:  2011-09-01       Impact factor: 4.160

5.  Safety and efficacy of fidaxomicin in the treatment of Clostridium difficile-associated diarrhea.

Authors:  Yoav Golan; Lauren Epstein
Journal:  Therap Adv Gastroenterol       Date:  2012-11       Impact factor: 4.409
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.